Attached files

file filename
8-K - U.S. PHYSICAL THERAPY, INC. 8-K - U S PHYSICAL THERAPY INC /NVa6818926.htm

Exhibit 99.1

U. S. Physical Therapy Reports Second Quarter and Six Months 2011 Results

Company Declares Quarterly Dividend

HOUSTON--(BUSINESS WIRE)--August 4, 2011--U.S. Physical Therapy, Inc. (NasdaqGS: USPH), a national operator of outpatient physical therapy clinics, today reported Company record results for the quarter and six months ended June 30, 2011.

U.S. Physical Therapy’s net income for the quarter ended June 30, 2011 increased 10.1% to $4.9 million from $4.5 million in the second quarter of 2010. Diluted earnings per share rose to $.41 from $.38.

Net income for the six months ended June 30, 2011 increased 13.4% to $8.6 million from $7.6 million in the first six months of 2010. Diluted earnings per share rose to $.72 from $.64.


Second Quarter 2011 compared to Second Quarter 2010

  • Net revenue increased 10.7% from $54,103,000 in the second quarter of 2010 to $59,912,000 in the second quarter of 2011, due to an increase in patient visits of 8.7% from 497,000 to 541,000, offset by a slight decrease in average net patient revenue per visit of $0.35 from $105.12 to $104.77. Other revenues included a $1.3 million year-over-year quarterly increase in physician services revenue.
  • Gross margin was 28.2% for the 2011 second quarter as compared to 28.7% in the 2010 second quarter. Total clinic operating costs were $43,023,000, or 71.8% of net revenue, in the second quarter of 2011, as compared to $38,602,000, or 71.3% of net revenue, in the 2010 period. Clinic salaries and related costs were 51.9% of net revenue in the 2011 period versus 51.1% in the 2010 period. Rent, clinic supplies, contract labor and other costs as a percentage of net revenue were approximately 19.0% in both periods. The provision for doubtful accounts as a percentage of net revenue was 0.8% for the 2011 period versus 1.4% in the 2010 period.
  • Corporate office costs were $6,007,000 in the second quarter of 2011 versus $5,511,000 in the 2010 second quarter. Corporate office costs were approximately 10.0% of net revenues in both periods.
  • Operating income increased in the second quarter of 2011 to $10,882,000 from $9,990,000 in the 2010 second quarter. The operating income margin percentage was 18.2% in the second quarter of 2011 as compared to 18.5% in the second quarter of 2010.
  • Interest expense increased to $109,000 in the second quarter of 2011 from $81,000 in the second quarter of 2010.
  • Provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interests was 39.3% in both periods.
  • Net income attributable to common shareholders in the second quarter of 2011 rose 10.1% to $4,900,000 from $4,451,000 in the second quarter of 2010. Diluted earnings per share increased to $.41 from $.38.
  • Same store revenues for de novo and acquired clinics open for one year or more decreased by 1.2%. The average net rate per visit increased slightly while same store visits decreased slightly.
  • During the second quarter of 2011, the Company opened two start-up de novo clinics and closed one clinic. The Company ended the period with 398 clinics.

Six Months 2011 compared to Six Months 2010

  • Net revenue increased 11.6% from $104,508,000 in the first six months of 2010 to $116,653,000 in the first six months of 2011, due to an increase in patient visits of 9.3% from 966,000 to 1,056,000, and a slight increase in average net patient revenue per visit of $0.05 from $104.62 to $104.67. Other revenues included a $2.4 million increase in physician services revenue between the comparable six months periods.
  • Gross margin increased to 27.5% in the 2011 first six months as compared to 26.8% in the 2010 period. Total clinic operating costs were $84,601,000, or 72.5% of net revenue in 2011, as compared to $76,536,000, or 73.2% of net revenue, in 2010. Clinic salaries and related costs were 52.1% of net revenue in both periods. Rent, clinic supplies, contract labor and other costs as a percentage of net revenue were 19.4% in 2011 versus 19.5% in the 2010 period. The provision for doubtful accounts was 1.0% in the 2011 period and 1.7% in the 2010 period.
  • Corporate office costs were $12,488,000 in the first six months of 2011 versus $11,316,000 in the 2010 first six months. Corporate office costs were approximately 11.0% of net revenues in both periods.
  • Operating income increased in the first six months of 2011 to $19,564,000 from $16,656,000 in the 2010 first six months. The operating income margin percentage was 16.8% in the first six months of 2011 as compared to 15.9% in the first six months of 2010.
  • Other income in the first six months of 2010 included a pre-tax gain of $578,000 from the sale of a five clinic joint venture. That gain equated to net income after taxes of approximately $350,000 or $.03 in earnings per share.
  • Interest expense increased to $182,000 in the first six months of 2011 from $145,000 in the first six months of 2010.
  • Provision for income taxes as a percentage of income before taxes less net income attributable to non-controlling interests was 39.3% in both periods.
  • Net income attributable to common shareholders in the first six months of 2011 rose 13.4% to $8,646,000 from $7,623,000 in the first six months of 2010. Diluted earnings per share increased to $.72 from $.64.
  • Same store revenues for de novo and acquired clinics open for one year or more decreased slightly. The average net rate per visit increased by 1.0% while same store visits decreased by 1.2%. Revenue and visit percentages were adjusted to reflect equivalent days of operations between periods.
  • During the first six months of 2011, the Company opened eight start-up de novo clinics and closed two clinics. The Company ended the period with 398 clinics.

Chris Reading, Chief Executive Officer, said, “In spite of the challenges with respect to pricing (MPPR) and volume pressures, we have delivered another strong quarter and year-to-date period of growth. Our team recognizes that we have opportunity however with respect to operational efficiencies that we need to realize. Given the strength of our partners, combined with the focus of our operational team, I am confident we will make progress within our existing business. We also see continued opportunities to expand our footprint with well placed, partner-centric acquisitions like the 20 clinic transaction we recently announced. These factors, combined with strong growth in our physician services business, provide us with plenty of fuel to further develop and grow our business.”

U.S. Physical Therapy Declares Quarterly Dividend

The Company announced that a quarterly dividend of $.08 per share will be paid on September 2, 2011 to shareholders of record as of August 19, 2011.

U.S. Physical Therapy's management will host a conference call at 10:30 am Eastern Time, 9:30 am Central Time, on Thursday, August 4, 2011 to discuss the Company’s Second Quarter and First Six Months 2011 results. Interested parties may participate in the call by dialing 1-888-335-5539 or 973-582-2857 and enter reservation number 82822785 approximately 10 minutes before the call is scheduled to begin. To listen to the live call via web-cast, go to the Company's website at www.usph.com at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived and can be accessed for approximately 120 days at this website.

Forward-Looking Statements

This press release contains statements that are considered to be forward-looking within the meaning under Section 21E of the Securities Exchange Act of 1934. These statements contain forward-looking information relating to the financial condition, results of operations, plans, objectives, future performance and business of our Company. These statements (often using words such as “believes”, “expects”, “intends”, “plans”, “appear”, “should” and similar words) involve risks and uncertainties that could cause actual results to differ materially from those we project. Included among such statements are those relating to opening new clinics, availability of personnel and the reimbursement environment. The forward-looking statements are based on our current views and assumptions and actual results could differ materially from those anticipated in such forward-looking statements as a result of certain risks, uncertainties, and factors, which include, but are not limited to:


  • changes in Medicare guidelines and reimbursement or failure of our clinics to maintain their Medicare certification status;
  • revenue and earnings expectations;
  • general economic conditions;
  • business and regulatory conditions including federal and state regulations;
  • changes as the result of government enacted national healthcare reform;
  • availability and cost of qualified physical and occupational therapists;
  • personnel productivity;
  • competitive, economic or reimbursement conditions in our markets which may require us to reorganize or close certain clinics and thereby incur losses and/or closure costs including the possible write-down or write-off of goodwill and other intangible assets;
  • changes in reimbursement rates or payment methods from third party payors including government agencies and deductibles and co-pays owed by patients;
  • maintaining adequate internal controls;
  • availability, terms, and use of capital;
  • acquisitions, purchase of non controlling interests (minority interests) and the successful integration of the operations of the acquired businesses; and
  • weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you should not place undue reliance on our forward-looking statements. Please see our periodic reports filed with the Securities and Exchange Commission (the "SEC") for more information on these factors. Our forward-looking statements represent our estimates and assumptions only as of the date of this press release. Except as required by law, we are under no obligation to update any forward-looking statement, regardless of the reason the statement is no longer accurate.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 418 clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, non-surgical treatment of osteoarthritis, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages physical therapy facilities for third parties, including hospitals and physician groups.

More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.


         
U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF NET INCOME
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)
 
Three Months Ended June 30, Six Months Ended June 30,
2011 2010 2011 2010
 
 
Net patient revenues $ 56,678 $ 52,296 $ 110,550 $ 101,075
Other revenues   3,234     1,807     6,103     3,433  
Net revenues 59,912 54,103 116,653 104,508
 
Clinic operating costs:
Salaries and related costs 31,120 27,644 60,759 54,415
Rent, clinic supplies, contract labor and other 11,388 10,238 22,683 20,338
Provision for doubtful accounts 504 734 1,128 1,768
Closure costs   11     (14 )   31     15  
Total clinic operating costs 43,023 38,602 84,601 76,536
 
Corporate office costs   6,007     5,511     12,488     11,316  
 
Operating income 10,882 9,990 19,564 16,656
 
Interest and other income, net 2 2 4 582
Interest expense   (109 )   (81 )   (182 )   (145 )
 
Income before taxes 10,775 9,911 19,386 17,093
Provision for income taxes   3,172     2,877     5,598     4,928  
 
Net income including noncontrolling interests 7,603 7,034 13,788 12,165
Less: net income attributable to noncontrolling interests   (2,703 )   (2,583 )   (5,142 )   (4,542 )
Net income attributable to common shareholders $ 4,900   $ 4,451   $ 8,646   $ 7,623  
 
Earnings per share attributable to common shareholders:
Basic $ 0.42   $ 0.38   $ 0.73   $ 0.66  
 
Diluted $ 0.41   $ 0.38   $ 0.72   $ 0.64  
 
Shares used in computation:
Basic   11,807     11,622     11,767     11,618  
 
Diluted   11,999     11,857     11,978     11,849  
 
Dividends declared per common share $ 0.08   $ -   $ 0.16   $ -  
 

         
U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
 
CONSOLIDATED EARNINGS PER SHARE
(IN THOUSANDS, EXCEPT PER SHARE DATA)
(unaudited)
 
Three Months Ended Six Months Ended
June 30, June 30,
2011 2010 2011 2010
Numerator:
Net income attributable to common shareholders $ 4,900 $ 4,451 $ 8,646 $ 7,623
 
Denominator:

Denominator for basic earnings per share - weighted-average shares

11,807 11,622 11,767 11,618

Effect of dilutive securities - Stock options

  192   235   211   231

Denominator for diluted earnings per share - adjusted weighted-average shares

  11,999   11,857   11,978   11,849
 
Earnings per share attributable to common shareholders:
Basic $ 0.42 $ 0.38 $ 0.73 $ 0.66
 
Diluted $ 0.41 $ 0.38 $ 0.72 $ 0.64

     
U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
 
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT SHARE DATA)
 
June 30, December 31,
2011 2010
(unaudited)
ASSETS
 
Current assets:
Cash $ 8,992 $ 9,179

Patient accounts receivable, less allowance for doubtful accounts of $2,570 and $2,190, respectively

27,468 24,814

Accounts receivable - other, less allowance for doubtful accounts of $136 and $83, respectively

2,613 1,555
Other current assets   5,179     3,736  
Total current assets 44,252 39,284
 
Fixed assets:
Furniture and equipment 33,953 33,563
Leasehold improvements   19,733     19,590  
53,686 53,153
Less accumulated depreciation and amortization   40,940     39,230  
12,746 13,923
Goodwill 76,588 79,424
Other intangible assets, net 9,948 7,308
Other assets   3,303     922  
$ 146,837   $ 140,861  
 
LIABILITIES AND SHAREHOLDERS' EQUITY
 
Current liabilities:
Accounts payable - trade $ 1,517 $ 1,237
Accrued expenses 12,734 12,744
Current portion of notes payable   434     250  
Total current liabilities 14,685 14,231
Notes payable 334 250
Revolving line of credit 15,800 5,500
Deferred rent 849 966
Other long-term liabilities   587     3,531  
Total liabilities 32,255 24,478
 
Commitments and contingencies
 
Shareholders' equity:
U. S. Physical Therapy, Inc. shareholders' equity:

Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding

- -

Common stock, $.01 par value, 20,000,000 shares authorized, 14,103,592 and 13,893,157 shares issued, respectively

141 139
Additional paid-in capital 37,513 45,570
Retained earnings 96,632 89,876
Treasury stock at cost, 2,214,737 shares   (31,628 )   (31,628 )
Total U. S. Physical Therapy, Inc. shareholders' equity 102,658 103,957
Noncontrolling interests   11,924     12,426  
Total equity   114,582     116,383  
$ 146,837   $ 140,861  

     
U. S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(unaudited)
 
Six Months Ended June 30,
2011 2010
 
OPERATING ACTIVITIES
Net income including noncontrolling interests $ 13,788 $ 12,165

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operating activities:

Depreciation and amortization 2,752 2,865
Provision for doubtful accounts 1,128 1,768
Equity-based awards compensation expense 963 578
(Gain) loss on sale of business and sale or abandonment of assets, net 75 (408 )
Deferred income tax 950 453
Other (591 ) (162 )
Changes in operating assets and liabilities:
Increase in patient accounts receivable (3,728 ) (2,059 )
Increase in accounts receivable - other (1,112 ) (234 )
Increase in other assets (1,251 ) (401 )
Decrease in accounts payable and accrued expenses (548 ) (2,086 )
Increase in other liabilities   415     61  
Net cash provided by operating activities 12,841 12,540
 
INVESTING ACTIVITIES
Purchase of fixed assets (1,484 ) (1,588 )
Purchase of businesses, net of cash acquired - (8,878 )
Acquisitions of noncontrolling interests (15,885 ) (215 )
Net proceeds on sale of fixed assets and business   4     895  
Net cash used in investing activities (17,365 ) (9,786 )
 
FINANCING ACTIVITIES
Distributions to noncontrolling interests (4,597 ) (4,831 )
Cash dividends to shareholders (1,890 ) -
Proceeds from revolving line of credit 42,300 27,800
Payments on revolving line of credit (32,000 ) (24,600 )
Payment of notes payable (100 ) (476 )
Excess tax benefit from stock options exercised 622 12
Proceeds from exercise of stock options   2     88  
Net cash provided by (used in) financing activities 4,337 (2,007 )
 
Net increase (decrease) in cash (187 ) 747
Cash - beginning of period   9,179     6,429  
Cash - end of period $ 8,992   $ 7,176  
 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Income taxes $ 3,367 $ 4,787
Interest $ 188 $ 115
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion $ - $ 225
Acquisition of noncontrolling interest - seller financing portion $ 367 $ -

 
U.S. PHYSICAL THERAPY, INC. AND SUBSIDIARIES
RECAP OF CLINIC DEVELOPMENT ACTIVITY
           
Number
of
Opened Acquired Sold Closed Clinics
 

At December 31, 2008

360
First Quarter 2009, March 31, 2009 6 - - (1 ) 365
Second Quarter 2009, June 30, 2009 3 - - (2 ) 366
Third Quarter 2009, September 30, 2009 5 - - (4 ) 367
Fourth Quarter 2009, December 31, 2009 4 - -   (3 ) 368
Year Ended, December 31, 2009 18 - -   (10 ) 368
 
First Quarter 2010, March 31, 2010 1 5 (5 ) (2 ) 367
Second Quarter 2010, June 30, 2010 7 - - (5 ) 369
Third Quarter 2010, September 30, 2010 5 - - (2 ) 372
Fourth Quarter 2010, December 31, 2010 6 20 -   (6 ) 392
Year Ended, December 31, 2010 19 25 (5 ) (15 ) 392
 
First Quarter 2011, March 31, 2011 6 - - (1 ) 397
Second Quarter 2011, June 30, 2011 2 - -   (1 ) 398
Six Months Ended, June 30, 2011 8 - -   (2 ) 398

CONTACT:
U.S. Physical Therapy, Inc.
Larry McAfee, 713-297-7000
Chief Financial Officer
or
Chris Reading, 713-297-7000
Chief Executive Officer
or
The Ruth Group
Stephanie Carrington, 646-536-7017
or
Amy Glynn, 646-536-7023